Harshit Udani

Associate Director, Global Patient Safety and Risk Management

Role: Associate Director, Global Patient Safety and Risk Management at Alnylam Pharmaceuticals
Location: New York, NY, US
LinkedIn followers: 500 followers

About Harshit Udani

With over a decade of experience in the life sciences sector, specializing in Drug Safety Systems, I bring a proven track record as an accomplished leader. My expertise includes successfully leading teams through complex projects such as Argus implementations and upgrades, Reporting and Signaling Solution implementations, and Data Migrations. I excel in pre-sales activities, such as cost estimation, budgeting, resourcing, scoping, and contract management. Additionally, I am proficient in Safety Systems Management, implementing best practices for Configurations, Customizations, Aggregate Reporting, and E2B Gateway integrations.

Experience

Associate Director, Global Patient Safety and Risk Management
Alnylam Pharmaceuticals
Oct 2021 — Present

Education

Lamar University
Master's degree
2008 — 2010
University of Mumbai
Bachelor's degree
2003 — 2007

Contact information

Verified work emails, personal emails, and direct dials — unlocked in one click.

Work email
h•••••@alnylam.com
Personal email
•••••@•••••.com
Direct dial
+•• ••• ••• ••••

Unlock verified contacts

Free to start · No credit card required

Current company

Alnylam Pharmaceuticals

Biotechnology Research · 3K employees · Founded 2002 · Cambridge, Massachusetts, United States

SILENCE DISEASE. AMPLIFY LIFE.™ Alnylam is a leading independent biopharmaceutical company and the pioneer in RNA interference (RNAi) therapeutics – a revolutionary approach to treating diseases which “silences” the genes that cause or contribute to them. Founded in 2002 by a group of distinguished researchers and biotech leaders, Alnylam’s work over more than two decades has yielded the critical breakthroughs and advancements that have made the field of (RNAi) therapeutics possible. In 2018, our first commercial medicine, and the world’s first RNAi therapeutic was approved. Since then, five more Alnylam-developed medicines have been approved and we’re hard at work developing new therapies to treat both rare and prevalent diseases. We are a global and diverse company of 2,600+ people. We pride ourselves on fostering a fun, inclusive and dynamic work environment where employees can recognize their fullest potential. That's why we’re consistently ranked as a top employer by The Boston Globe (2015-25), Science Magazine (2018-25), Fast Company (Best Workplaces for Innovators 2020-25) and Great Place to Work. We are based in Cambridge, Massachusetts (U.S.), with offices throughout North America, Europe, Asia, and South America. See our social media community guidelines: https://bit.ly/2FcRhJy. Please note: If you wish to report an adverse event or product complaint, please email m••••••@alnylam.com or you may call us using the following telephone numbers: for North America, 877.ALNYLAM (87••••••26), for Europe, +31•••••••61 Fraudulent Recruitment Activity Be aware of the potential for scams and fraudulent recruitment activity from individuals claiming to represent Alnylam Pharmaceuticals. Alnylam never conducts its interview process via messaging apps, freelance sites, or social media platforms. Alnylam team members only communicate with potential candidates through an official Alnylam email address ending in "@alnylam.com."

alnylam.com

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Start for free See how it works

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

About Harshit Udani

Experience

Associate Director, Global Patient Safety and Risk Management

Education

Lamar University

University of Mumbai

Find verified contacts for anyone on LinkedIn